Posted Jun. 26, 2012 at 9:03 a.m.

Premium Lock Pozen secures second patent for its drug technology

Published: 2012-06-26 09:03:36
Updated: 2012-06-26 09:03:36

Print this blog post

Pozen (Nasdaq: POZN) hasn't gotten any pain relief from the FDA recently - but it has from the U.S. Patent and Trademark Office....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Frank Vinluan
Life science
Vivek Wadhwa
Dr. Mike Walden
Tech economy